Worth a watch. Good summary of where each agent is at - Vittorio speaks very well. Nice to see some plans are being made for a couple of the other products that had been on the back burner too. Hoping the Lantheus PDL1 imaging trial results come out shortly - I am desperately hoping we bring in some upfront cash for our China rights to be able to push on with funding our other targets. In terms of the therapeutic PDL1 currently in phase 1 - Lantheus would be keeping a close eye any results later this year you'd think.
Ann: RAD to present at NWR Virtual Healthcare Conference, page-2
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.57M | |||
| Open | High | Low | Value | Volume |
| 3.7¢ | 3.8¢ | 3.6¢ | $20.29K | 557.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 120798 | 3.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.6¢ | 48086 | 1 |
View Market Depth
| Last trade - 15.49pm 20/05/2024 (20 minute delay) ? |
|
|||||
|
Last
3.7¢ |
Change
0.000 ( 2.78 %) |
||||
| Open | High | Low | Volume | ||
| 3.7¢ | 3.7¢ | 3.6¢ | 197414 | ||
| Last updated 14.03pm 20/05/2024 ? | |||||
| RAD (ASX) Chart |